Glenmark Pharmaceuticals
GLENMARK.NS
#2590
Rank
S$7.39 B
Marketcap
$26.20
Share price
0.55%
Change (1 day)
104.44%
Change (1 year)

Earnings for Glenmark Pharmaceuticals (GLENMARK.NS)

Earnings in 2024 (TTM): S$0.12 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company's current earnings are S$1.42 Billion. In 2023 the company made an earning of -S$81.23 Million a decrease over its 2022 earnings that were of S$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Glenmark Pharmaceuticals from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.12 B-259.7%
2023 -S$81.23 Million-129.25%
2022 S$0.27 B-13.93%
2021 S$0.32 B4.71%
2020 S$0.30 B18.76%
2019 S$0.25 B-15.93%
2018 S$0.30 B36.53%
2017 S$0.22 B-31.84%
2016 S$0.33 B66.82%
2015 S$0.19 B8.58%
2014 S$0.18 B-18.39%
2013 S$0.22 B3.66%
2012 S$0.21 B